🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI
$274.62
+101.08% 1Y
Mkt Cap$38.36B
P/E-180.67
P/B22.40
52W High$283.80
52W Low$136.57
Book Value$12.26
EPS (TTM)$-1.52

Company Overview

NTRA (NTRA) is a publicly traded company listed on with a market capitalization of $38.36B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Steady Revenue Expansion

Revenue has grown at a 40.4% CAGR over the past five years.

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.13.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Dec 2025 Revenue of $2.31B (+35.9% YoY); net profit $-208.16M.
  • Trailing 12 Months Year-on-year growth — revenue +35.9%.
  • 5-Year Trend Long-term compounding — revenue CAGR 40.4%.

Growth & Price Performance

Compounded Sales Growth

5 Years:40.40%
1 Year:35.90%

Stock Price Performance

1 Year:+101.08%
6 Months:+20.62%
3 Months:+32.81%
1 Month:-2.36%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 94% of range
$136.57 $283.80
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)60.03 · Neutral
Price Performance
1M-2.36%
3M+32.81%
6M+20.62%
1Y+101.08%

Auto-generated from price history and fundamentals; not investment advice.

Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Compounding revenue at 40.4% over 5 years.
  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

Ad space

Valuation

Stock P/E
-180.67
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$12.26
Price to Book
22.40
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
40.40%
Profit 5Y
-
Revenue (YoY)
35.90%
Earnings (YoY)
-

Profitability & Returns

ROCE
-15.84%
ROE
-12.16%
ROA
-8.68%
Profit Margin
-9.03%
Op Margin
-13.44%
Gross Margin
64.75%
EPS (Latest Qtr)
$-0.60
EPS (TTM)
$-1.52

Balance Sheet & Liquidity

Debt/Equity
0.13
Quick Ratio
3.24
Current Ratio
3.39
Debt
$214.38M
Total Assets
$2.61B
Current Assets
$1.65B
Working Capital
$1.06B

Ownership

Promoter Holding
2.89%
Chg in Prom Hold
0.00%
FII / Inst Holding
96.02%
Chg in FII Hold
0.00%

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$2.31B
EBITDA
$-220.54M
Free Cash Flow
$76.11M
Operating Cash Flow
$215.30M
Shares Outstanding
139.69M
Gross Margin
64.75%
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue --------49.38M52.28M55.91M52.05M62.34M63.07M65.28M66.97M66.82M74.36M77.91M83.24M94.01M86.47M98.14M152.32M142.03M158.12M194.13M198.20M210.64M241.76M261.40M268.31M367.74M413.35M439.76M501.83M546.60M592.18M665.50M696.64M
Cost of Revenue -----------------------------------185.06M200.00M207.80M220.07M245.81M
Gross Profit 22.59M19.36M14.46M21.10M29.56M21.01M19.63M11.30M15.68M17.72M21.30M15.32M21.75M22.07M23.60M24.18M23.52M30.53M34.03M38.78M---------------316.76M346.60M384.38M445.43M450.83M
Operating Expenses -----------------------------------395.94M456.98M481.96M468.21M544.35M
Operating Income -6.28M-15.47M-20.74M--9.61M-22.52M-26.66M--34.55M-28.37M-25.79M--30.52M-27.22M-27.17M--31.75M-28.64M-21.09M--34.87M-51.66M-55.78M-63.02M-115.29M-150.20M-137.13M-143.09M-119.05M-138.30M-112.43M-110.98M-74.31M-43.90M-39.34M-79.18M-110.37M-97.58M-22.79M-93.52M
EBITDA ------------------------------------56.52M-89.78M-76.00M1.76M-63.69M
Interest Expense -----------------------------------1.00M1.03M1.04M991.00K892.00K
Pretax Income ------------------------------------66.76M-100.66M-87.34M-13.33M-84.81M
Tax Provision -----------------------------------173.00K275.00K207.00K-60.58M283.00K
Net Income -10.00M-19.68M-17.63M-22.96M-8.69M-23.16M-26.02M-37.91M-33.48M-29.07M-27.86M-47.22M-32.87M-33.82M-29.62M-31.84M-34.09M-32.42M-23.14M-35.18M-35.37M-59.64M-58.32M-63.85M-116.03M-151.27M-138.59M-145.15M-121.48M-136.94M-110.80M-109.03M-67.60M-37.46M-31.59M-66.94M-100.94M-87.54M47.26M-85.09M
Diluted EPS ---0.39--0.17-0.46-0.50-0.72-0.65-0.55-0.52-0.90-0.61-0.62-0.49-0.51-0.54-0.48-0.33-0.46----0.74-1.32-1.63-1.45-1.50-1.25-1.23-0.97-0.95-0.56-0.30-0.26-0.50-0.74-0.64--0.60
R&D Expense 5.63M6.74M7.34M-8.76M10.30M11.35M-12.65M11.79M12.61M-14.34M11.85M12.39M-11.44M12.12M12.80M-18.23M23.00M26.42M40.19M53.75M98.46M80.41M82.58M65.51M82.31M78.17M77.23M88.64M89.11M96.93M129.08M146.43M173.41M-210.70M

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 55.17M159.29M190.35M212.51M209.62M257.65M302.33M391.00M-820.22M1.08B1.70B2.31B
Cost of Revenue ---------456.26M589.83M673.75M812.93M
Gross Profit ---------363.97M492.74M1.02B1.49B
Operating Expenses ---------905.01M938.99M1.25B1.80B
Operating Income -25.27M665.00K-59.84M-101.05M-135.34M-114.63M-116.29M-216.28M--541.04M-446.25M-222.29M-309.91M
EBITDA ----------520.80M-397.80M-148.08M-220.54M
Interest Expense ---------9.32M12.64M10.69M4.07M
Pretax Income ----------546.82M-434.53M-189.73M-268.09M
Tax Provision ---------978.00K271.00K695.00K-59.93M
Net Income -37.11M-5.15M-70.28M-100.33M-137.63M-128.15M-124.83M-229.74M--547.80M-434.80M-190.43M-208.16M
Diluted EPS ---2.68-1.95-2.59-2.22-1.79-2.84--5.57-3.78-1.53-1.52
R&D Expense 11.55M17.29M27.71M41.86M50.06M51.35M51.36M100.03M264.21M316.42M320.68M404.14M624.11M

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --123.62M265.24M210.68M214.61M268.17M582.66M932.15M-1.39B1.44B1.66B2.40B
Current Assets ----------1.21B1.26B1.38B1.50B
Cash & Equivalents 5.75M30.50M87.18M28.95M15.26M12.62M46.41M61.93M48.67M-466.09M642.10M945.59M1.08B
Inventory ----------35.41M40.76M44.74M68.44M
Receivables ----------244.38M278.29M314.17M296.53M
Total Liabilities --54.35M80.47M104.20M189.20M236.01M303.94M445.92M-688.73M676.37M465.31M685.93M
Current Liabilities --29.87M80.47M96.42M105.56M113.98M179.87M199.05M-310.50M307.27M344.05M441.23M
Long Term Debt ---------280.39M281.65M282.94M--
Total Debt ----------446.22M441.99M187.12M214.38M
Total Equity -136.31M-171.51M-171.34M226.43M143.58M25.42M32.16M278.71M486.24M-705.74M765.33M1.20B1.71B
Shares Outstanding ----------111.25M119.58M132.65M139.69M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow ---37.83M-74.05M-97.83M-70.58M-63.44M-182.51M--431.50M-246.96M135.66M215.30M
Investing Cash Flow ---210.68M47.03M13.78M-5.16M-266.35M-331.46M-330.34M168.50M137.62M-132.21M
Financing Cash Flow --190.28M13.18M80.37M113.72M340.77M500.85M-482.64M254.46M30.20M47.46M
Capital Expenditure -8.24M-9.96M-7.85M-23.14M-9.87M-3.88M-4.97M-19.60M--47.70M-39.20M-76.92M-139.19M
Free Cash Flow ---45.68M-97.19M-107.69M-74.46M-68.41M-202.12M--479.20M-286.15M58.75M76.11M
Net Change in Cash ---------381.48M176.00M303.49M130.55M

Ratios (Annual)

Figures in %.

Metric Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % ---------44.4%45.5%60.3%64.7%
Operating Margin % -45.8%0.4%-31.4%-47.6%-64.6%-44.5%-38.5%-55.3%--66.0%-41.2%-13.1%-13.4%
Net Margin % -67.3%-3.2%-36.9%-47.2%-65.7%-49.7%-41.3%-58.8%--66.8%-40.2%-11.2%-9.0%
ROE % 21.6%3.0%-31.0%-69.9%-541.5%-398.5%-44.8%-47.2%--77.6%-56.8%-15.9%-12.2%
ROCE % -0.7%-32.4%-88.4%-124.1%-74.3%-28.9%-29.5%--49.9%-39.3%-16.9%-15.8%

Shareholding Pattern

Insiders
2.89%
Institutions
96.02%
Public Float
98.87%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for NTRA

Google News Wed, 05 Aug 2026

After U.S. approval, Natera submits bladder cancer test in Japan - Stock Titan

<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxNcWY4ckRSNTNFQ21PWjlTQjU5OTNuSnh6UFZVQWhENjBQUjk2RTltYVBPRHBFUmxkUjl0eE9OT0JOcEZRem1mWkZrUDFpcGpRX1pmMHpUYlpxMUdXTWxvcDNzbVR0UC1iUXh3R2dSbjFWTlVpSHpnUWgwNXFjTDVIMkJIWFBVT2RiaDJOS1…

Google News Fri, 31 Jul 2026

Natera (NTRA) Stock Looks Overvalued Despite Strong Signatera Optimism - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQMWM1SjlUM0ZxZWMtdUtONWhVSEN4NG9RLW95VEhXZTR0c2tEa1NvLThtREswMElQb3NtOG5RdTJEN2RVNGYtRVlmOUhLUjg0REpqRjFnX21nVFF6QkhvNWNBeUFGRTQtclBVc1RuWnI4QjREczI4cWRmU1NvUlNKWTd5NTIzNGwxNmhRUC…

Google News Sun, 02 Aug 2026

Natera (NTRA) Stock Trades At A Premium To Sales After A 425% Return - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxNRHNGMU9IazhvMVhsZzhTMVlWd2lDTGp5ZklobklGZ21lSjUyNU9IeVY3MWhIMkN4ZGFGUUx5QVBvS3Q1aDBONkJqQ3dVUVl5Wl9GU0lfYWxKUjkzNVpuX3IxdzNrY2Vxd2ttdEFKN1lyNG5qUTNvQnJxRExHSFk1RkZDVUM2dU1icllyMm…

Google News Wed, 05 Aug 2026

Natera (NTRA) Reports Q2: Everything You Need To Know Ahead Of Earnings - StockStory

<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxPZjJZQnphTkFhdW9kSVlEOGtNZkZnb1J0bnRaeVYyQmVHRU11RWJqdG5OcVNCMlViMWJuRk1qSnJJeHhtM0JvRmt3NlFabTFXTWg0WXlJa2dINElsd20yY2hnRFZmdVJ1TDdRLVRmTG82NmpUQzVuYlhxaFRia1B0WWJkS1doWTJEYll6TU…

Google News Sat, 01 Aug 2026

Natera (NTRA) Sets Earnings Date, Is The Stock Fully Priced? - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxOWHFMN1lXOHNycDVTelg3QVRtcDdFYkJVN2lUcmVQblNzdUV4emtpTEhfU0NiNGxObEtnd2ZaODZCY3pqellFd2tEXzgwcmk0X0Zlbk93WHRDT0VSTEZ6Yzl3emVzMERjVUdjekdiYmlaMThrb2J0VzJxS1VteGwxRkVkZTA4MGNKX2U1TT…

Google News Mon, 03 Aug 2026

NTRA (NASDAQ: NTRA) plans sale of common stock holdings - Stock Titan

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxNM0QtZTNEZ0M3dlF6ZlBhdTJ5OVgwNlFKZWpJX0dyV0lObHNRSEs2OEk3WTA5M1kxV2FQTEh6WHh2TE9qam5uem84Um5ZZEFBam5pTlBrZWgyMHV0T0NNU2UyYnhWd2tvOW83YXF2UFAwUVNKQWM2S2twcmNLSUVXMkhQZ192UVpma2Fua0…

NTRA — Frequently Asked Questions

What is the current share price of NTRA?

As of 2026-08-05 17:25 PDT, NTRA trades at $274.62 on NASDAQ/NYSE. Its 52-week range is $136.57 to $283.80.

What is the market capitalisation of NTRA?

NTRA has a market capitalisation of $38.36B on NASDAQ/NYSE.

What is the P/E ratio of NTRA?

NTRA trades at a trailing price-to-earnings (P/E) ratio of -180.67. Its price-to-book (P/B) ratio is 22.40.

What is the return on equity (ROE) of NTRA?

NTRA has a return on equity (ROE) of -12.16%. Its return on capital employed (ROCE) is -15.84%.

Is NTRA a good stock to buy?

This page provides a data-driven analysis of NTRA, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks